CRISPR strategy to treat FSHD
Charis Himeda, PhD, will discuss her pioneering work to demonstrate that CRISPR gene-editing technology can be used to silence the DUX4 gene. She will give us an update about her progress toward developing a treatment, as well as answer your questions more generally about the revolutionary (and controversial) technology that has taken medical research by storm.

Aug 10, 2019 02:00 PM in Eastern Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: FSH Society.